Depression Test is a medical screening app for Android and iOS that uses the PHQ-9 questionnaire to help users evaluate depression symptom severity.
The App DNA
What makes this app unique?
The tool removes the friction of seeking an initial clinical assessment by providing an immediate, self-administered screening option.
For Individuals seeking to monitor their mental health symptoms and those looking for empirically-supported tools to manage clinical depression.
What does it look like?
Key features
Standardized nine-question clinical questionnaire to evaluate depression symptom severity.
Local security feature to restrict access to assessment results on the device.
Cross-links to five additional tools including Thought Diary and Safety Plan.
How much does it cost?
The app operates as a free, non-monetized component of a larger health suite, prioritizing user acquisition and clinical tool distribution.
Velocity
Dormant developmentnew contentShow more...
Development has stalled, with no new feature builds or updates released in the last 284 days. The app currently sits in a zombie state, as the last update was over 9 months ago. There is no evidence of active maintenance or ongoing support for the platform.
Who built it?
Inquiry Health
13+ apps tracked · Medical
User Sentiment
What do users think recently?
The recent review mood reads excited. Users appreciate the diagnostic questionnaire provides actionable insights that help users identify and address their mental health struggles and simple and efficient interface design allows users to track their symptoms without unnecessary friction or complexity. On the flip side, users report that the app forces premium purchases to access features or progress through the questionnaire.
How are ratings & reviews evolving?
Weekly average review rating
What users say, by theme
- The diagnostic questionnaire provides actionable insights that help users identify and address their mental health struggles
- Simple and efficient interface design allows users to track their symptoms without unnecessary friction or complexity
- The absence of aggressive paywalls for core assessment results makes the tool accessible to those in need
- Users report that the app forces premium purchases to access features or progress through the questionnaire
69 of 69 recent reviews analyzed · high confidence · Excited overall
Read the full review analysisUnlock 2 more frustration themes and 1 user request, each backed by review evidence.
Access the full report for freeCompetition
Competitive landscape for Depression Test
How's the Medical market?
Depression Test maintains a steady presence in the Medical category, with a 4.23 rating on Android and 4.72 on iOS. The lack of updates for nearly nine months limits its ability to compete with more active health-tracking platforms.
Read the market outlookThe rivals identified
Unlock the deeper market read.
Access the full report for freeThe Analyst's Read
Key takeaways for Depression Test
Where is it heading?
The medical screening market is shifting toward integrated, data-rich health platforms that offer more than just a static questionnaire. Depression Test remains in maintenance mode, and its failure to modernize its data-sharing capabilities leaves it exposed to more agile competitors that prioritize user-owned health data.
- The nine-month development gap suggests the tool is in maintenance mode, which prevents it from answering user requests for native health integration.
- Persistent user complaints regarding paywall barriers erode the trust required for a medical screening tool, which compounds the risk of long-term user churn.
The SWOT
- PHQ-9 standardization provides clinical credibility
- Local passcode lock protects sensitive health data
- Integration with MoodTools suite creates retention loops
- Implement native Apple Health and Google Fit data sync
- Refine frequency options to capture nuanced symptom data
Next best moves
Audit paywall placement because user complaints regarding blocked results drive negative sentiment → improve retention and brand trust.
+ 1 more prioritized moveThe counter-intuitive read
The app's biggest risk is not its lack of features…
Read the full takeSince the last report: The app's competitive outlook has declined from mixed to declining due to prolonged development inactivity and persistent user frustration over monetization barriers. The core value proposition remains stagnant while competitors advance with integrated health tracking.
Bottom line
Depression Test relies on its clinical utility to maintain a user base, but the lack of updates and intrusive upsell prompts create a churn risk. Addressing the paywall friction would stabilize the user experience, while native health integration would unlock long-term retention.
Unlock 3 critical frictions, 2 market threats, 1 more prioritized move and the analyst’s take.
Access the full report for freeSources
- [1] Play Store listing, source
Report last updated